Anti-Drug-Resistant Compound Library | 抗耐药性化合物库 | MedChemExpress (MCE)

Resistance refers to the decrease in the effectiveness of drugs in treating diseases or symptoms. Due to the increasing global antibiotic resistance, it may threaten our ability to treat common infectious diseases. Drug resistance is also the main cause of chemotherapy failure in malignant tumors. In approximately 50% of cases, drug resistance exists even before chemotherapy begins. There are many mechanisms of anticancer drug resistance, including increased protein expression that leads to drug removal, mutations in drug binding sites, recovery of tumor protein production, and pre-existing genetic heterogeneity in tumor cell populations. In addition, the issue of drug resistance seems to have affected the development of new anticancer drugs. Drug resistance may be caused by various conditions, such as mutations, epigenetic modifications, and upregulation of drug efflux protein expression. Overcoming multidrug resistance in cancer treatment is becoming increasingly important. MCE designs a unique collection of 388 anti-drug-resistant compounds. It is a good tool to be used for research on cancer and other diseases. 更多产品详情查看：www.medchemexpress.cn/screening/anti-drug-resistant-compound-library.html

Anti-Drug-Resistant Compound Library | 抗耐药性化合物库 | MedChemExpress (MCE)信息由MedChemExpress (MCE)为您提供，如您想了解更多关于Anti-Drug-Resistant Compound Library | 抗耐药性化合物库 | MedChemExpress (MCE)报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途